Vanguard Group’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $15.8M | Sell |
|
|||||
|
2021
Q2 | $21.4M | Buy |
|
|||||
|
2021
Q1 | $21.7M | Buy |
|
|||||
|
2020
Q4 | $27.4M | Buy |
|
|||||
|
2020
Q3 | $24M | Buy |
|
|||||
|
2020
Q2 | $29.9M | Buy |
|
|||||
|
2020
Q1 | $13.9M | Sell |
|
|||||
|
2019
Q4 | $36.7M | Sell |
|
|||||
|
2019
Q3 | $24.5M | Sell |
|
|||||
|
2019
Q2 | $23.1M | Buy |
|
|||||
|
2019
Q1 | $21.2M | Buy |
|
|||||
|
2018
Q4 | $18.5M | Buy |
|
|||||
|
2018
Q3 | $30.3M | Buy |
|
|||||
|
2018
Q2 | $41.4M | Buy |
|
|||||
|
2018
Q1 | $34.7M | Buy |
|
|||||
|
2017
Q4 | $36.5M | Buy |
|
|||||
|
2017
Q3 | $27.5M | Buy |
|
|||||
|
2017
Q2 | $21.3M | Buy |
|
|||||
|
2017
Q1 | $26.8M | Buy |
|
|||||
|
2016
Q4 | $18.3M | Buy |
|
|||||
|
2016
Q3 | $16.3M | Buy |
|
|||||
|
2016
Q2 | $10.4M | Buy |
|
|||||
|
2016
Q1 | $4.51M | Buy |
|
|||||
|
2015
Q4 | $8.61M | Buy |
|
|||||
|
2015
Q3 | $6.49M | Buy |
|
|||||
|
2015
Q2 | $8.75M | Buy |
|
|||||
|
2015
Q1 | $4.69M | Buy |
|
|||||
|
2014
Q4 | $2.54M | Buy |
|
|||||
|
2014
Q3 | $543K | Buy |
|
|||||
|
2014
Q2 | $278K | Buy |
|